Please sign in to follow a disease.
Sleep apnea device may keep heart rhythm in check
NCT ID NCT07358429
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether using a CPAP machine at night can reduce the chance of atrial fibrillation (an irregular heartbeat) returning in people who have both sleep apnea and a history of AF. Researchers will follow 91 adults for 12 months, tracking how often they use CPAP and checking for AF recurrence with ECG and Holter monitors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Continuous Positive Airway Pressure (CPAP) device
- What this could lead to
- If CPAP adherence reduces AF recurrence, it could point to a simple way to manage heart rhythm problems in sleep apnea patients.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. CPAP adherence varies, and the small size (91 people) limits how much we can conclude.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
91 people
The number who actually took part.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients diagnosed with moderate-to-severe obstructive sleep apnea and a history of paroxysmal atrial fibrillation, managed in outpatient and hospital settings, and treated with continuous positive airway pressure therapy as part of routine clinical care.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years 2. Diagnosed moderate-to-severe OSA 3. History of paroxysmal atrial fibrillation 4. Ability to initiate CPAP therapy 5. Written informed consent - Exclusion Criteria: 1. Left ventricular ejection fraction \< 50% 2. Permanent atrial fibrillation 3. Central sleep apnea 4. End-stage chronic kidney disease 5. Inability to obtain or tolerate CPAP therapy -
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrial fibrillation (paroxysmal) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UMHAT "Tcaritca Joanna - ISUL"
Sofia, 1000, Bulgaria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New mask aims to make sleep apnea therapy easier to live with
- Can a weekly phone call keep sleep apnea patients on CPAP?
- A smart neck brace may replace CPAP for sleep apnea
- A blood test for liver trouble may flag hidden risk in sleep apnea patients
- Blood oxygen dips may reveal who stays on CPAP
- Can a simple questionnaire improve sleep apnea treatment?